Research studies serve to validate strategies, treatments and devices to prove they are beneficial to humans. They open the pathway for innovation and an understanding of certain diseases or methods. Yet, even with their continued importance, less than 10% of them end up being published, even after extensive development. Unfortunately, innovation in the methods used to run these studies are obsolete and end up costing trials $600,000–$8 million per day to manage data. Systems often censor data or put it behind a paywall, which stifles innovation, and are fairly expensive to manage, providing no net benefit to all. Scintillating's flagship product, reBlock, aims to solve the considerable issues in studies today, by using the blockchain to greatly reduce costs and increase transparency between researchers and participants. Using this technology, data collection, maintainability and overall participation in studies can be improved, and thus opens that pathway for research availability.